The hot area for venture capitalists this year.
Source of US buying I suppose.
Too many good points to even begin commenting on presentation.
One that I need to highlight is COPD.
ie sleep disorders.
probably bigger than asma and probably same technology platform.
Phenomenal share price growth for years, not just months in my humble opinion
